Form D · Other Health Care

Akari Therapeutics Plc

Tampa, FL · CIK 0001541157

Offering snapshot reported Jun 3, 2026 · SEC filing

Reported sold
$1.83M
Offering amount: $5.5M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 20, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 3, 2026Initial$1,833,333No comparison6SEC filing
Oct 24, 2025Initial$6,250,000No comparison4SEC filing
Jan 9, 2024Initial$2,000,001No comparison2SEC filing
Oct 19, 2023Initial$1,971,001No comparison11SEC filing
Sep 27, 2022Initial$12,835,000No comparison21SEC filing
Jul 22, 2021Initial$12,318,688No comparisonNot reportedSEC filing
Mar 11, 2020Initial$9,554,528No comparison53SEC filing
Jul 12, 2019Initial$4,499,945No comparison45SEC filing
Sep 28, 2015Initial$75,000,000No comparison28SEC filing
Sep 30, 2013Initial$12,516,232No comparison18SEC filing
Feb 1, 2013Initial$931,000No comparison7SEC filing
Dec 13, 2012Amendment$1,503,000$0vs Dec 12, 201220SEC filing
Dec 12, 2012Initial$1,503,000No comparison20SEC filing
Apr 13, 2012InitialYet to sellNo comparison2SEC filing

Offering details

Securities
Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$125K
Finders' fees
$0
Form D file number
021-586106
Offering of ADSs, Pre-Funded Warrants, Series H, I and J Warrants, each convertible into one ADS for $5,500,000. Approximately $1,833,333 raised to date. The issuance of Series Warrants are subject to shareholder approval.
American Depositary Shares (ADSs), each representing 80,000 Ordinary Shares
Paulson is also entitled to a fee equal to 2.0% of the gross proceeds, a non-accountable expense of $15,000, and 117,647 Placement Agent ADSs. The issuance of the Placement Agent ADSs are subject to receipt of shareholder approval.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Paulson Investment Company, LLC000005670

Source: Form D, filed Jun 3, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rob Bazemore Director
Joe Bondi Executive
Melissa Bradford Klug Executive
David Byrne Director
Yuval Cohen Director, Executive
Mark Cohen Director
Wendy Di Cicco Executive
Robert Doman Director
Amos Eiran Director
Dov Elefant Director, Executive
Kameel Farag Executive
Peter Feldschreiber Director
Abizer Gaslightwala Director, Executive
Michael Grissinger Director
Alan Harris Executive
Wa'el Hashad Director
James Hill Director
Torsten Hombeck Executive
Hoyoung Huh Director
Rachelle Jacques Director, Executive
Johnson Lau Director
Jim Neal Director
Miles Nunn Executive
Sandip Patel Director
Samir Patel Director
Fredric Price Director
Ray Prudo Director
Dr. Ray Prudo Director
Gilead Raday Director
Clive Richardson Director, Executive
Gur Roshwalb Director, Executive
Allan Shaw Director
David Sidransky Director
Stuart Ungar Director
Donald Williams Director
Saul Yedgar Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
401 East Jackson Street Suite 3300
Tampa, FL, 33602
Phone: (929) 274-7510